An open-label, phase 2, single centre, randomised, crossover study of two doses of Androfeme in healthy postmenopausal wome
Phase 2
Completed
- Conditions
- determination of blood testosterone levels using two doses of Androfem cream in postmenopausal womenReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12612001250820
- Lead Sponsor
- Monash University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 8
Inclusion Criteria
Healthy naturally postmenopausal women aged 50-65 years
Exclusion Criteria
Allergy to almonds, major medical disorders or on recent hormonal treatment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method